Treatment of pyoderma gangrenosum

被引:2
|
作者
Anstey, AV
机构
关键词
THIOPURINE METHYLTRANSFERASE ACTIVITY; GENETIC-POLYMORPHISM; AZATHIOPRINE; PHARMACOGENETICS;
D O I
10.1016/S0190-9622(97)80356-8
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:802 / 802
页数:1
相关论文
共 50 条
  • [31] Recalcitrant pyoderma gangrenosum: Treatment with thalidomide
    Hecker, MS
    Lebwohl, MG
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 38 (03) : 490 - 491
  • [32] Pyoderma Gangrenosum: An Ulcer With Unorthodox Treatment
    Baruah, Tridip Dutta
    Ray, Rubik
    Manju, R.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)
  • [33] Infliximab as a treatment for recalcitrant pyoderma gangrenosum
    Singh, M
    Andrew, SM
    Lear, JT
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2004, 29 (02) : 196 - 197
  • [34] Treatment of pyoderma gangrenosum with mycophenolate mofetil
    Kim, L. K. P.
    Hong, E.
    Cooper, A. J.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2011, 52 : 31 - 32
  • [35] TREATMENT OF PYODERMA-GANGRENOSUM WITH CYCLOSPORINE
    MATIS, WL
    ELLIS, CN
    GRIFFITHS, CEM
    LAZARUS, GS
    CLINICAL RESEARCH, 1991, 39 (02): : A507 - A507
  • [36] TREATMENT OF PYODERMA-GANGRENOSUM WITH METHOTREXATE
    TEITEL, AD
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S163 - S163
  • [37] The treatment of pyoderma gangrenosum using etanercept
    Roy, DB
    Conte, ET
    Cohen, D
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : S128 - S134
  • [38] TREATMENT OF PYODERMA-GANGRENOSUM WITH CYCLOSPORINE
    MATIS, WL
    ELLIS, CN
    GRIFFITHS, CEM
    LAZARUS, GS
    ARCHIVES OF DERMATOLOGY, 1992, 128 (08) : 1060 - 1064
  • [39] Cavitary pyoderma gangrenosum and a novel treatment
    Tallon, Ben
    Rademaker, Marius
    Parkinson, Grant
    Whitley, Brian
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB43 - AB43
  • [40] Tofacitinib for the treatment of refractory pyoderma gangrenosum
    Orfaly, V. E.
    Kovalenko, I
    Tolkachjov, S. N.
    Ortega-Loayza, A. G.
    Nunley, J. R.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2021, 46 (06) : 1082 - 1085